[Abstract] The hepatitis B virus (HBV) is an important global human pathogen and represents a major cause of hepatitis, liver cirrhosis and liver cancer. The HBV capsid is composed of multiple copies of a single viral protein, the capsid or core protein (HBc), plays multiple roles in the viral life cycle, and has emerged recently as a major target for developing antiviral therapies against HBV infection. Although several systems have been developed to study HBV capsid assembly, including heterologous overexpression systems like bacteria and insect cells, in vitro assembly using purified protein, and mammalian cell culture systems, the requirement for non-physiological concentrations of HBc and salts and the difficulty in manipulating host regulators of assembly presents major limitations for detailed studies on capsid assembly under physiologically relevant conditions. We have recently developed a mammalian cell-free system based on the rabbit reticulocyte lysate (RRL), in which HBc is expressed at physiological concentrations and assembles into capsids under near-physiological conditions. This system has already revealed HBc assembly requirements that are not anticipated based on previous assembly systems. Furthermore, capsid assembly in this system is regulated by endogenous host factors that can be readily manipulated. Here we present a detailed protocol for this cell-free capsid assembly system, including an illustration on how to manipulate host factors that regulate assembly.
binding activities (Hatton et al., 1992) and plays important roles in viral RNA packaging (Nassal, 1992) , DNA synthesis (Nassal, 1992; Yu and Summers, 1994) , and nuclear import of capsids (Liao and Ou, 1995; Liu et al., 2015) , all of which is further regulated by the dynamic phosphorylation state of CTD controlled by host factors (Kann and Gerlich, 1994 ; Kann et al., 1999; Daub et al., 2002; Ludgate et al., 2012; Liu et al., 2015) . Whether CTD, and its state of phosphorylation, play a role in capsid assembly under physiological conditions remained unclear.
To study HBV capsid assembly under more physiological conditions, we have recently developed a mammalian cell-free assembly system based on the commonly used mammalian cell extract, rabbit reticulocyte lysate (RRL), in which HBc is expressed at physiological (low) concentrations (25-50 nM, monomer) and assembles into capsids under near-physiological conditions (Ludgate et al., 2016) . This system allowed us to reveal an unexpected role of CTD in capsid assembly, which is further subjected to regulation by the state of CTD phosphorylation as controlled by endogenous host factors (Ludgate et al., 2016) . This protocol is adapted from Ludgate et al. (2016) and more detailed information on this cell-free capsid assembly system is included, and different treatments are applied to address the roles of viral and host factors, such as RNA-binding activities of CTD and host phosphatases, in HBV capsid assembly under near-physiological conditions. This protocol will facilitate detailed studies on capsid assembly and host regulation under physiological conditions and identification of novel antiviral agents targeting HBc. www.bio-protocol.org/e2813 Moreover, CTD is subject to phosphorylation and dephosphorylation by endogenous host kinase(s) and phosphatase(s) in RRL, which further regulates capsid assembly.
Materials and Reagents
To confirm the roles of CTD in capsid assembly in RRL, especially its RNA binding activity and regulation of assembly by phosphorylation state, the following treatments, as shown in Figure 1 , are applied to the HBc in vitro assembly assay in RRL.
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Data analysis
The expression of HBc and capsid assembly in this cell-free system can be examined using SDS-PAGE, agarose gel electrophoresis, and Western blot, as shown in Figure 2 
